Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Resilience of men and the gap hypothesis of quality of life: Health utility outcome measurement in prostate cancer.

Glaser AW.

Eur Urol. 2019 Aug 16. pii: S0302-2838(19)30607-4. doi: 10.1016/j.eururo.2019.07.046. [Epub ahead of print] No abstract available.

PMID:
31427124
2.

Life and bladder cancer: protocol for a longitudinal and cross-sectional patient-reported outcomes study of Yorkshire (UK) patients.

Mason SJ, Downing A, Wright P, Bottomley SE, Winterbottom A, Glaser AW, Catto JWF.

BMJ Open. 2019 Jun 17;9(6):e030850. doi: 10.1136/bmjopen-2019-030850. Erratum in: BMJ Open. 2019 Jul 9;9(7):e030850corr1.

3.

Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy.

Wilding S, Downing A, Wright P, Selby P, Watson E, Wagland R, Donnelly DW, Hounsome L, Butcher H, Mason M, Henry A, Gavin A, Glaser AW.

Qual Life Res. 2019 Oct;28(10):2741-2751. doi: 10.1007/s11136-019-02212-x. Epub 2019 May 21.

4.

Regional Variations in Quality of Survival Among Men with Prostate Cancer Across the United Kingdom.

Donnelly DW, Gavin A, Downing A, Hounsome L, Kearney T, McNair E, Allan D, Huws DW, Wright P, Selby PJ, Kind P, Watson E, Wagland R, Wilding S, Butcher H, Mottram R, Allen M, McSorley O, Sharp L, Mason MD, Cross WR, Catto JWF, Glaser AW.

Eur Urol. 2019 Aug;76(2):228-237. doi: 10.1016/j.eururo.2019.04.018. Epub 2019 May 4.

5.

Systematic evaluation of Patient-Reported Outcome protocol content and reporting in cancer trials.

Kyte D, Retzer A, Ahmed K, Keeley T, Armes J, Brown JM, Calman L, Gavin A, Glaser AW, Greenfield DM, Lanceley A, Taylor RM, Velikova G, Brundage M, Efficace F, Mercieca-Bebber R, King MT, Turner G, Calvert M.

J Natl Cancer Inst. 2019 Apr 11. pii: djz038. doi: 10.1093/jnci/djz038. [Epub ahead of print]

6.

Survival from cancer in young people: An overview of late effects focusing on reproductive health.

Newton HL, Friend AJ, Feltbower R, Hayden CJ, Picton HM, Glaser AW.

Acta Obstet Gynecol Scand. 2019 May;98(5):573-582. doi: 10.1111/aogs.13584. Epub 2019 Apr 8. Review.

PMID:
30773617
7.

Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study.

Downing A, Wright P, Hounsome L, Selby P, Wilding S, Watson E, Wagland R, Kind P, Donnelly DW, Butcher H, Catto JWF, Cross W, Mason M, Sharp L, Weller D, Velikova G, McCaughan E, Mottram R, Allen M, Kearney T, McSorley O, Huws DW, Brewster DH, McNair E, Gavin A, Glaser AW.

Lancet Oncol. 2019 Mar;20(3):436-447. doi: 10.1016/S1470-2045(18)30780-0. Epub 2019 Jan 31.

8.

Functional Outcomes and Health-Related Quality of Life After Curative Treatment for Rectal Cancer: A Population-Level Study in England.

Downing A, Glaser AW, Finan PJ, Wright P, Thomas JD, Gilbert A, Corner J, Richards M, Morris EJA, Sebag-Montefiore D.

Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1132-1142. doi: 10.1016/j.ijrobp.2018.12.005. Epub 2018 Dec 13.

PMID:
30553942
9.

Respiratory morbidity in young people surviving cancer: Population-based study of hospital admissions, treatment-related risk factors and subsequent mortality.

Smith L, Glaser AW, Peckham D, Greenwood DC, Feltbower RG.

Int J Cancer. 2019 Jul 1;145(1):20-28. doi: 10.1002/ijc.32066. Epub 2019 Jan 16.

PMID:
30549268
10.

Melatonin in children with cancer.

Glaser AW, Nicholson JC, Polanco A, Phillips B.

BMJ. 2018 Dec 10;363:k5164. doi: 10.1136/bmj.k5164. No abstract available.

11.

'Very difficult for an ordinary guy': Factors influencing the quality of treatment decision-making amongst men diagnosed with localised and locally advanced prostate cancer: Findings from a UK-wide mixed methods study.

Wagland R, Nayoan J, Matheson L, Rivas C, Brett J, Downing A, Wilding S, Butcher H, Gavin A, Glaser AW, Watson E.

Patient Educ Couns. 2019 Apr;102(4):797-803. doi: 10.1016/j.pec.2018.12.004. Epub 2018 Dec 3.

PMID:
30527732
12.

Treatment for erectile dysfunction among older men in Northern Ireland.

Donnelly DW, Kearney T, McCaughan E, Downing A, Weller D, Glaser AW, Gavin A.

Int J Clin Pract. 2019 Jan;73(1):e13259. doi: 10.1111/ijcp.13259. Epub 2018 Sep 17.

13.

Long-term survival after childhood acute lymphoblastic leukaemia: population-based trends in cure and relapse by clinical characteristics.

Smith L, Glaser AW, Kinsey SE, Greenwood DC, Chilton L, Moorman AV, Feltbower RG.

Br J Haematol. 2018 Sep;182(6):851-858. doi: 10.1111/bjh.15424. Epub 2018 May 29.

14.

Health-related quality of life after treatment for bladder cancer in England.

Mason SJ, Downing A, Wright P, Hounsome L, Bottomley SE, Corner J, Richards M, Catto JW, Glaser AW.

Br J Cancer. 2018 May;118(11):1518-1528. doi: 10.1038/s41416-018-0084-z. Epub 2018 May 14.

15.

Late effects of childhood cancer.

Friend AJ, Feltbower RG, Newton HL, Picton HM, Glaser AW.

Lancet. 2018 May 5;391(10132):1772. doi: 10.1016/S0140-6736(18)30572-5. No abstract available.

16.

Evaluating patient-reported outcome measures (PROMs) for bladder cancer: a systematic review using the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist.

Mason SJ, Catto JWF, Downing A, Bottomley SE, Glaser AW, Wright P.

BJU Int. 2018 Nov;122(5):760-773. doi: 10.1111/bju.14368. Epub 2018 Jun 8.

17.

Systematic review and meta-analysis investigating the efficacy and safety of probiotics in people with cancer.

Hassan H, Rompola M, Glaser AW, Kinsey SE, Phillips RS.

Support Care Cancer. 2018 Aug;26(8):2503-2509. doi: 10.1007/s00520-018-4216-z. Epub 2018 Apr 27.

PMID:
29704110
18.

Validation of a classification system for treatment-related mortality in children with cancer.

Hassan H, Rompola M, Glaser AW, Kinsey SE, Phillips RS.

BMJ Paediatr Open. 2017 Oct 30;1(1):e000082. doi: 10.1136/bmjpo-2017-000082. eCollection 2017.

19.

Urinary, bowel and sexual health in older men from Northern Ireland.

Donnelly DW, Donnelly C, Kearney T, Weller D, Sharp L, Downing A, Wilding S, Wright P, Kind P, Catto JWF, Cross WR, Mason MD, McCaughan E, Wagland R, Watson E, Mottram R, Allen M, Butcher H, Hounsome L, Selby P, Huws D, Brewster DH, McNair E, Rivas C, Nayoan J, Horton M, Matheson L, Glaser AW, Gavin A.

BJU Int. 2018 Nov;122(5):845-857. doi: 10.1111/bju.14182. Epub 2018 Mar 25.

20.

Mental health of long-term survivors of childhood and young adult cancer: A systematic review.

Friend AJ, Feltbower RG, Hughes EJ, Dye KP, Glaser AW.

Int J Cancer. 2018 Sep 15;143(6):1279-1286. doi: 10.1002/ijc.31337. Epub 2018 Mar 15.

21.

Fertility preservation options in prepubertal females: feasibility, safety and outcomes.

Newton HL, Glaser AW, Picton HM.

Minerva Ginecol. 2017 Dec;69(6):568-586. doi: 10.23736/S0026-4784.17.04117-X. Epub 2017 Jul 12. Review.

PMID:
28707851
22.

Patient-reported outcomes in cancer survivors: a population-wide cross-sectional study.

Jefford M, Ward AC, Lisy K, Lacey K, Emery JD, Glaser AW, Cross H, Krishnasamy M, McLachlan SA, Bishop J.

Support Care Cancer. 2017 Oct;25(10):3171-3179. doi: 10.1007/s00520-017-3725-5. Epub 2017 Apr 22.

PMID:
28434095
23.

Access to principal treatment centres and survival rates for children and young people with cancer in Yorkshire, UK.

Fairley L, Stark DP, Yeomanson D, Kinsey SE, Glaser AW, Picton SV, Evans L, Feltbower RG.

BMC Cancer. 2017 Mar 4;17(1):168. doi: 10.1186/s12885-017-3160-5.

24.

Changing Current Practice in Urology: Improving Guideline Development and Implementation Through Stakeholder Engagement.

MacLennan SJ, MacLennan S, Bex A, Catto JWF, De Santis M, Glaser AW, Ljungberg B, N'Dow J, Plass K, Trapero-Bertran M, Van Poppel H, Wright P, Giles RH.

Eur Urol. 2017 Aug;72(2):161-163. doi: 10.1016/j.eururo.2017.02.008. Epub 2017 Feb 22.

PMID:
28237788
25.

Life after prostate cancer diagnosis: protocol for a UK-wide patient-reported outcomes study.

Downing A, Wright P, Wagland R, Watson E, Kearney T, Mottram R, Allen M, Cairnduff V, McSorley O, Butcher H, Hounsome L, Donnelly C, Selby P, Kind P, Cross W, Catto JW, Huws D, Brewster DH, McNair E, Matheson L, Rivas C, Nayoan J, Horton M, Corner J, Verne J, Gavin A, Glaser AW.

BMJ Open. 2016 Dec 7;6(12):e013555. doi: 10.1136/bmjopen-2016-013555.

26.

Identifying Social Distress: A Cross-Sectional Survey of Social Outcomes 12 to 36 Months After Colorectal Cancer Diagnosis.

Wright P, Downing A, Morris EJ, Corner JL, Richards MA, Sebag-Montefiore D, Finan P, Glaser AW.

J Clin Oncol. 2015 Oct 20;33(30):3423-30. doi: 10.1200/JCO.2014.60.6129. Epub 2015 Aug 17.

PMID:
26282636
27.

Health-related quality of life after colorectal cancer in England: a patient-reported outcomes study of individuals 12 to 36 months after diagnosis.

Downing A, Morris EJ, Richards M, Corner J, Wright P, Sebag-Montefiore D, Finan P, Kind P, Wood C, Lawton S, Feltbower R, Wagland R, Vernon S, Thomas J, Glaser AW.

J Clin Oncol. 2015 Feb 20;33(6):616-24. doi: 10.1200/JCO.2014.56.6539. Epub 2015 Jan 5.

PMID:
25559806
28.

Prostate cancer outcomes: the three questions.

Glaser AW, Corner JL.

Eur Urol. 2015 Mar;67(3):357-8. doi: 10.1016/j.eururo.2014.10.023. Epub 2014 Nov 10.

PMID:
25454610
29.

Patient-reported outcomes of cancer survivors in England 1-5 years after diagnosis: a cross-sectional survey.

Glaser AW, Fraser LK, Corner J, Feltbower R, Morris EJ, Hartwell G, Richards M, Wagland R.

BMJ Open. 2013 Apr 10;3(4). pii: e002317. doi: 10.1136/bmjopen-2012-002317. Print 2013.

30.

Male and female experiences of having fertility matters raised alongside a cancer diagnosis during the teenage and young adult years.

Crawshaw MA, Glaser AW, Hale JP, Sloper P.

Eur J Cancer Care (Engl). 2009 Jul;18(4):381-90. doi: 10.1111/j.1365-2354.2008.01003.x.

PMID:
19594609
31.

Young males' experiences of sperm banking following a cancer diagnosis - a qualitative study.

Crawshaw MA, Glaser AW, Hale JP, Sloper P.

Hum Fertil (Camb). 2008 Dec;11(4):238-45. doi: 10.1080/14647270802132752.

PMID:
19085260
32.
33.

Long term morbidity and health related quality of life after multi-system Langerhans cell histiocytosis.

Nanduri VR, Pritchard J, Levitt G, Glaser AW.

Eur J Cancer. 2006 Oct;42(15):2563-9. Epub 2006 Sep 7.

PMID:
16959486
34.

PMS2 mutations in childhood cancer.

De Vos M, Hayward BE, Charlton R, Taylor GR, Glaser AW, Picton S, Cole TR, Maher ER, McKeown CM, Mann JR, Yates JR, Baralle D, Rankin J, Bonthron DT, Sheridan E.

J Natl Cancer Inst. 2006 Mar 1;98(5):358-61.

PMID:
16507833
35.

Epidemiology of central nervous system tumors in children and young adults (0-29 years), Yorkshire, United Kingdom.

Feltbower RG, Picton S, Bridges LR, Crooks DA, Glaser AW, McKinney PA.

Pediatr Hematol Oncol. 2004 Oct-Nov;21(7):647-60.

PMID:
15626021
36.

Fertility preservation in adolescent males with cancer in the United Kingdom: a survey of practice.

Glaser AW, Phelan L, Crawshaw M, Jagdev S, Hale J.

Arch Dis Child. 2004 Aug;89(8):736-7. No abstract available.

37.

Diagnosing childhood cancer in primary care--a realistic expectation?

Feltbower RG, Lewis IJ, Picton S, Richards M, Glaser AW, Kinsey SE, McKinney PA.

Br J Cancer. 2004 May 17;90(10):1882-4.

38.

Geographic mobility following cancer treatment in Yorkshire, UK.

Feltbower RG, Glaser AW, Parslow RC, Kinsey SE.

Arch Dis Child. 2004 Apr;89(4):380-1.

39.

Hospital attendance patterns in long term survivors of cancer.

Johnson R, Horne B, Feltbower RG, Butler GE, Glaser AW.

Arch Dis Child. 2004 Apr;89(4):374-7.

40.

Pneumocystis carinii pneumonia: a late presentation following treatment for stage IV neuroblastoma.

Clarke E, Glaser AW, Picton SV.

Pediatr Hematol Oncol. 2003 Sep;20(6):467-71.

PMID:
14631621
41.

Patterns of childhood cancer by ethnic group in Bradford, UK 1974-1997.

McKinney PA, Feltbower RG, Parslow RC, Lewis IJ, Glaser AW, Kinsey SE.

Eur J Cancer. 2003 Jan;39(1):92-7.

PMID:
12504664
42.

Applicability of the Health Utilities Index to a population of childhood survivors of central nervous system tumours in the U.K.

Glaser AW, Furlong W, Walker DA, Fielding K, Davies K, Feeny DH, Barr RD.

Eur J Cancer. 1999 Feb;35(2):256-61.

PMID:
10448268
43.

Children in residential care; what cost?

Polnay L, Glaser AW, Dewhurst T.

Arch Dis Child. 1997 Nov;77(5):394-5. Review. No abstract available.

44.

School behaviour and health status after central nervous system tumours in childhood.

Glaser AW, Abdul Rashid NF, U CL, Walker DA.

Br J Cancer. 1997;76(5):643-50.

45.
46.

Corticosteroids in the management of central nervous system tumours. Kids Neuro-Oncology Workshop (KNOWS).

Glaser AW, Buxton N, Walker D.

Arch Dis Child. 1997 Jan;76(1):76-8. No abstract available.

Supplemental Content

Loading ...
Support Center